Diversity Covering AMA1-MSP1 19 Fusion Proteins as Malaria Vaccines
- 1 May 2013
- journal article
- Published by American Society for Microbiology in Infection and Immunity
- Vol. 81 (5) , 1479-1490
Abstract
To overcome polymorphism in the malaria vaccine candidate Plasmodium falciparum apical membrane antigen 1 (PfAMA1), fusion protein chimeras comprised of three diversity-covering (DiCo) PfAMA1 molecules (D1, D2, and D3) and two allelic variants of the C-terminal 19-kDa region of merozoite surface protein 1 (MSP1 19 ) (variants M1 and M2) were generated. A mixture of fusion proteins (D1M1/D2M2D3) and the D1M1D2M2D3 fusion were compared to a single-unit mixture (D1/D2/D3/M1) in an immunological study in groups of rabbits. Following immunization, titers of antibodies (Abs) against four naturally occurring PfAMA1 alleles were high for all groups, as were growth inhibition assay (GIA) levels against two antigenically distinct laboratory parasite strains. Fusion of AMA1 to MSP1 19 did not suppress levels of antibodies against the AMA1 component. In addition, the breadth of antibody responses was unaffected. Anti-AMA1 antibodies were largely responsible for parasite growth inhibition, as shown in reversal-of-inhibition experiments by adding competing AMA1 antigen. For all groups, titration of the MSP1 19 antigen into the GIA led to only a small decrease in parasite inhibition, although titers of antibodies against MSP1 19 were increased 15-fold for the groups immunized with fusion proteins. GIA with affinity-purified anti-MSP1 19 antibodies showed that the 50% inhibitory concentrations of the anti-MSP1 19 antibody preparations were in the same order of magnitude for all animals tested, leading to the conclusion that fusing MSP1 19 to PfAMA1 leads to a small but significant increase in functional antibody levels. This study shows that combination of multiple vaccine candidates in fusion proteins may lead to improved characteristics of the vaccine.Keywords
This publication has 51 references indexed in Scilit:
- Global malaria mortality between 1980 and 2010: a systematic analysisThe Lancet, 2012
- Immunization with different Pf AMA1 alleles in sequence induces clonal imprint humoral responses that are similar to responses induced by the same alleles as a vaccine cocktail in rabbitsMalaria Journal, 2011
- Generation of Humoral Immune Responses to Multi-Allele PfAMA1 Vaccines; Effect of Adjuvant and Number of Component Alleles on the Breadth of ResponsePLOS ONE, 2010
- World Trade Report 20102010
- Humoral Immune Response to Mixed PfAMA1 Alleles; Multivalent PfAMA1 Vaccines Induce Broad SpecificityPLOS ONE, 2009
- From malaria control to eradication: The WHO perspectiveTropical Medicine & International Health, 2009
- Impact of Artemisinin-Based Combination Therapy and Insecticide-Treated Nets on Malaria Burden in ZanzibarPLOS Medicine, 2007
- Structure of AMA1 from Plasmodium falciparum reveals a clustering of polymorphisms that surround a conserved hydrophobic pocketProceedings of the National Academy of Sciences, 2005
- Genetically modified Plasmodium parasites as a protective experimental malaria vaccineNature, 2004
- Safety, Immunogenicity, and Efficacy of a Recombinantly Produced Plasmodium falciparum Circumsporozoite Protein-Hepatitis B Surface Antigen Subunit VaccineThe Journal of Infectious Diseases, 1995